Dive into the dynamic realm of Pfizer (NYSE: PFE) with insights from our expert analysts in this engaging episode of the Motley Fool Scoreboard. Watch the video below to uncover critical market trends, valuable insights, and potential investment opportunities that could shape your portfolio!
*Stock prices referenced were as of Feb. 19, 2025. The video was published on March 27, 2025.
Wondering where to strategically invest $1,000 today? Our dedicated analyst team has unveiled what they consider to be the 10 best stocks to invest in right now. Discover More »
Is Now the Right Time to Invest $1,000 in Pfizer?
Prior to making a stock purchase in Pfizer, it’s essential to evaluate this critical information:
The Motley Fool Stock Advisor analyst team recently identified what they deem to be the 10 best stocks for investors to consider right now, and notably, Pfizer did not make the list. The selected 10 stocks are projected to generate impressive returns in the years ahead, making them attractive options for savvy investors.
Take, for example, when Nvidia was included in this list on April 15, 2005… if you had invested $1,000 at that time based on our recommendation, you’d now have $697,245!*
The Stock Advisor service offers investors a straightforward roadmap for achieving financial success. This includes comprehensive guidance on effective portfolio building, regular updates from seasoned analysts, and two fresh stock picks each month. Since its inception in 2002, the Stock Advisor service has remarkably more than quadrupled the returns of the S&P 500 index. Ensure you don’t miss out on the latest top 10 list by joining Stock Advisor today!
View the 10 stocks now »
*Stock Advisor returns as of March 24, 2025
Karl Thiel holds positions in Pfizer. Keith Speights also has positions in Pfizer. The Motley Fool maintains positions in and recommends Pfizer. The Motley Fool adheres to a strict disclosure policy.
